Price
Financials
Standalone, Rs crore| Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1.41 | 0.91 | 3.62 | 12.16 | 5.87 | 2.16 | 6.92 | 6.18 | 7.24 | 4.78 | 3.87 | 7.12 |
| Expenses | 0.92 | 1.33 | 8.21 | 15.43 | 12.04 | 10.76 | 9.95 | 7.44 | 7.81 | 7.42 | 7.31 | 8.73 |
| Operating Profit | 0.49 | -0.42 | -4.59 | -3.27 | -6.17 | -8.60 | -3.03 | -1.26 | -0.57 | -2.64 | -3.44 | -1.61 |
| OPM % | 34.75% | -46.15% | -126.80% | -26.89% | -105.11% | -398.15% | -43.79% | -20.39% | -7.87% | -55.23% | -88.89% | -22.61% |
| Other Income | 0.05 | 0.10 | 0.04 | 0.04 | 0.13 | 0.01 | 0.05 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.12 | 0.32 | 0.31 | 0.36 | 0.39 |
| Depreciation | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.04 | 0.03 |
| Profit before tax | 0.53 | -0.33 | -4.56 | -3.24 | -6.05 | -8.62 | -2.99 | -1.39 | -0.90 | -2.96 | -3.84 | -2.02 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Net Profit | 0.53 | -0.33 | -4.56 | -3.24 | -6.05 | -8.62 | -2.99 | -1.39 | -0.90 | -2.96 | -3.84 | -2.02 |
| EPS in Rs | 0.20 | -0.13 | -1.75 | -1.25 | -2.33 | -3.32 | -1.15 | -0.53 | -0.35 | -1.14 | -1.48 | -0.78 |
| Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2.13 | 6.17 | 15.81 | 2.85 | 5.24 | 5.96 | 4.54 | 6.32 | 4.13 | 23.81 | 25.12 | 23.01 |
| Expenses | 92.99 | 106.89 | 108.78 | 5.67 | 7.65 | 5.80 | 3.73 | 5.19 | 4.19 | 46.43 | 32.62 | 31.27 |
| Operating Profit | -90.86 | -100.72 | -92.97 | -2.82 | -2.41 | 0.16 | 0.81 | 1.13 | -0.06 | -22.62 | -7.50 | -8.26 |
| OPM % | -4,265.73% | -1,632.41% | -588.05% | -98.95% | -45.99% | 2.68% | 17.84% | 17.88% | -1.45% | -95.00% | -29.86% | -35.90% |
| Other Income | 1.07 | -0.25 | -0.13 | 0.33 | 0.71 | 0.22 | 0.37 | 0.26 | 0.29 | 0.22 | 0.05 | 0.01 |
| Interest | 10.45 | 24.90 | 38.55 | 0.00 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.75 | 1.38 |
| Depreciation | 9.80 | 10.62 | 11.33 | 4.62 | 4.62 | 4.61 | 4.64 | 4.63 | 0.04 | 0.04 | 0.04 | 0.09 |
| Profit before tax | -110.04 | -136.49 | -142.98 | -7.11 | -6.36 | -4.23 | -3.46 | -3.24 | 0.19 | -22.46 | -8.24 | -9.72 |
| Tax % | 0.74% | -4.91% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | |
| Net Profit | -110.85 | -129.79 | -142.98 | -7.11 | -6.36 | -4.23 | -3.46 | -3.24 | 0.19 | -22.47 | -8.24 | -9.72 |
| EPS in Rs | -43.47 | -50.90 | -56.07 | -2.73 | -2.45 | -1.63 | -1.33 | -1.25 | 0.07 | -8.64 | -3.17 | -3.75 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 10 Years | 5 Years | 3 Years | TTM | 1 Year | Last Year | |
|---|---|---|---|---|---|---|
| Compounded Sales Growth | 28% | 33% | 58% | 9% | ||
| Compounded Profit Growth | 7% | -45% | % | 49% | ||
| Stock Price CAGR | -14% | % | % | % | ||
| Return on Equity | % | % | % | % |
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 25.45 | 25.45 | 25.45 | 25.45 | 25.96 | 25.96 | 25.96 | 25.96 | 25.96 | 25.96 | 25.96 | 25.96 |
| Reserves | 66.50 | -44.35 | -172.37 | -314.62 | -3.64 | -10.00 | -14.23 | -17.69 | -20.97 | -20.91 | -43.39 | -51.50 |
| Borrowings | 0.00 | 135.00 | 327.50 | 484.50 | 0.00 | 0.25 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 13.44 |
| Other Liabilities | 20.91 | 46.53 | 25.36 | 32.96 | 2.00 | 0.57 | 0.94 | 0.52 | 1.24 | 0.68 | 25.53 | 20.04 |
| Total Liabilities | 112.86 | 162.63 | 205.94 | 228.29 | 24.32 | 16.78 | 12.67 | 8.79 | 6.23 | 5.73 | 8.10 | 7.94 |
| Fixed Assets | 90.16 | 94.17 | 89.14 | 201.23 | 18.91 | 14.29 | 9.68 | 5.03 | 0.40 | 0.36 | 0.31 | 0.27 |
| CWIP | 20.39 | 58.30 | 91.80 | 2.59 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 2.31 | 10.16 | 25.00 | 24.47 | 5.41 | 2.49 | 2.99 | 3.76 | 5.83 | 5.37 | 7.79 | 7.67 |
| Total Assets | 112.86 | 162.63 | 205.94 | 228.29 | 24.32 | 16.78 | 12.67 | 8.79 | 6.23 | 5.73 | 8.10 | 7.94 |
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operating Activity | 19.26 | -69.12 | -118.30 | -99.24 | -1.66 | -2.91 | 1.06 | 0.06 | 2.19 | -0.47 | -0.95 | -13.70 |
| Cash from Investing Activity | -19.63 | -54.27 | -43.46 | -34.77 | -0.30 | 0.00 | -0.01 | -0.61 | -1.34 | -0.35 | 2.55 | 0.00 |
| Cash from Financing Activity | 0.53 | 125.44 | 168.72 | 129.08 | 0.51 | 0.25 | -0.29 | 0.00 | 0.00 | 0.00 | 0.00 | 12.78 |
| Net Cash Flow | 0.16 | 2.05 | 6.96 | -4.93 | -1.45 | -2.66 | 0.76 | -0.55 | 0.85 | -0.81 | 1.60 | -0.92 |
| Free Cash Flow | -0.52 | -124.11 | -161.76 | -134.02 | -1.68 | -2.91 | 1.06 | 0.06 | 2.19 | -0.47 | -0.95 | -13.70 |
| CFO/OP | -24% | 75% | 117% | 106% | 59% | 121% | 662% | 7% | 194% | 783% | 5% | 183% |
| Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 87.39 | 62.71 | 30.01 | 238.21 | 121.20 | 87.58 | 147.13 | 84.90 | 109.59 | 15.33 | 9.30 | |
| Inventory Days | 92.17 | 653.96 | 1,749.39 | 27.75 | 0.00 | 0.00 | 68.19 | 77.00 | 68.16 | 9.33 | 5.84 | |
| Days Payable | 13,663.54 | 2,937.97 | 4,333.07 | 166.49 | 88.24 | 89.32 | 85.75 | 84.54 | 914.45 | |||
| Cash Conversion Cycle | -13,483.97 | -2,221.31 | -2,553.67 | 99.47 | 121.20 | 87.58 | 127.07 | 72.58 | 92.00 | -59.89 | -899.31 | |
| Working Capital Days | -5,463.00 | -563.77 | -388.78 | 10.25 | 87.77 | 36.74 | 148.73 | 56.02 | 126.38 | -300.16 | -197.47 | |
| ROCE % | -198.96% | -95.72% | -75.03% | -55.44% | -6.53% | -32.81% | -30.28% | -34.60% | -48.87% | 3.78% |
| Dec 2016 | Mar 2017 | Jun 2017 | Sep 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 57.54% | 57.54% | 57.54% | 57.54% | 56.08% | 56.08% | 56.08% | 56.08% | 56.08% | 56.08% | 56.08% | 56.08% |
| FIIs | 0.64% | 0.64% | 0.64% | 0.64% | 0.64% | 0.64% | 0.64% | 0.64% | 0.64% | 0.64% | 0.64% | 0.64% |
| DIIs | 3.41% | 3.44% | 3.42% | 3.38% | 3.38% | 3.38% | 3.38% | 3.38% | 3.38% | 3.38% | 3.38% | 3.37% |
| Public | 38.41% | 38.38% | 38.40% | 38.44% | 38.44% | 38.45% | 38.45% | 38.45% | 38.45% | 38.45% | 38.45% | 38.45% |
| Others | 0.00% | 0.00% | 0.00% | 0.00% | 1.46% | 1.46% | 1.46% | 1.46% | 1.46% | 1.46% | 1.46% | 1.46% |
| No. of Shareholders | 53,701 | 53,306 | 52,693 | 52,269 | 50,836 | 50,668 | 50,213 | 49,589 | 49,164 | 48,622 | 48,182 | 47,837 |
Fundamentals
Market Cap₹ 58.9 Cr.
Current Price₹ 22.7
Book Value₹ -12.1
ROCE%
ROE%
Dividend Yield0.00 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)9%
Compounded Profit Growth (TTM)49%
Standalone figures.
Valuation
Market capRs 59 Cr
Enterprise valueRs 71 Cr
Price to book-2.31x
Price to sales2.56x
EV / sales3.10x
Earnings yield-16.49%
P/E, 3-year average1130.64x
P/B, 3-year average11.02x
P/E, 5-year average1130.64x
P/B, 5-year average16.16x
Profitability
Operating margin (excl. other income)-29.86%
Operating margin (incl. other income)-29.66%
EBITDA margin-35.85%
Pre-tax margin-42.24%
Net profit margin-42.24%
Net margin, latest quarter-28.37%
ROE38.35%
ROA-102.74%
ROE, 3-year average135.05%
ROCE, 3-year average3.78%
ROA, 3-year average-141.50%
ROE, 5-year average64.33%
ROCE, 5-year average-26.56%
ROA, 5-year average-99.98%
Other income / net worth-0.20%
Growth
Sales growth (latest year)5.50%
Sales CAGR, 3 years58.40%
Sales CAGR, 5 years33.34%
Sales growth QoQ83.98%
Sales growth YoY (latest quarter)15.21%
Per share
EPS (TTM)Rs -3.74
EPS (latest year)Rs -3.17
EPS (latest quarter)Rs -0.78
EPS, 3-year averageRs -3.92
EPS, 5-year averageRs -2.87
Book value per shareRs -9.84
Sales per shareRs 8.86
Cash flow per shareRs -5.28
Free cash flow per shareRs -5.28
Efficiency
Asset turnover3.16x
Fixed asset turnover93.04x
Inventory turnover64.08x
Inventory days6 days
Debtor days9 days
Debtors turnover39.25x
Creditor days914 days
Cash conversion cycle-899 days
Working capital days-197 days
Leverage
Total debtRs 13 Cr
Cash and bankRs 1 Cr
Net debtRs 12 Cr
Debt to equity-0.53x
Interest coverage-6.04x
Owners' fund to total sources-321.66%
Debt to assets169.27%
Cash flow
Cash from Operating Activity (latest year)Rs -14 Cr
Cash from Financing Activity (latest year)Rs 13 Cr
Net Cash Flow (latest year)Rs -1 Cr
Free cash flow (latest year)Rs -14 Cr
Statement figures
Net sales (TTM)Rs 23 Cr
Net sales (latest year)Rs 25 Cr
Sales (latest quarter)Rs 7 Cr
Operating profit excl. other income (latest year)Rs -8 Cr
Operating profit (latest quarter)Rs -2 Cr
Other income (TTM)Rs 0 Cr
EBITDA (TTM)Rs -8 Cr
PBDT (TTM)Rs -10 Cr
Profit before tax (TTM)Rs -10 Cr
Net profit (TTM)Rs -10 Cr
Net profit (latest year)Rs -8 Cr
Net profit (latest quarter)Rs -2 Cr
Depreciation (TTM)Rs 0 Cr
Depreciation (latest quarter)Rs 0 Cr
Interest (TTM)Rs 1 Cr
Cost of goods sold (latest year)Rs 8 Cr
Total expenditure (latest year)Rs 33 Cr
Total income (latest year)Rs 25 Cr
Share capitalRs 26 Cr
ReservesRs -52 Cr
Shareholders' fundsRs -26 Cr
Total assetsRs 8 Cr
Net blockRs 0 Cr
ReceivablesRs 1 Cr
InventoryRs 0 Cr
Other liabilitiesRs 20 Cr
Shares outstanding (crore)2.60
Ownership
Promoter holding56.08% (+0.00 in a year)
Computed by MarketFriction from the standalone statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
| Period | PIRPHYTO | Nifty 50 | Difference |
|---|---|---|---|
| 1 week | -7.5% | -2.8% | -4.8 pts |
| 1 month | -7.0% | -6.8% | -0.2 pts |
| 3 months | -13.4% | -7.6% | -5.7 pts |
| 6 months | -22.1% | +0.4% | -22.5 pts |
| 1 year | -24.3% | -9.9% | -14.4 pts |
| 2 years | -70.5% | -13.6% | -57.0 pts |
| 3 years | -75.4% | +14.2% | -89.6 pts |
| 5 years | -45.2% | +27.9% | -73.1 pts |
Red flags
F-score 4 of 8| serious | Negative equity Shareholders' equity is negative |
| explain | High accruals Profit exceeded operating cash by 69% of total assets in 2019 |
| look | Repeated losses Net loss in each of the last two years |
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.
Latest quarter
Sep 2019Sales ₹7 Cr +15.2% vs Sep 2018.
Net loss ₹2 Cr.
Activity
Compare| Company | Mcap (Cr) | P/E | ROCE |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | 447,476 | 35.4 | 20.5 % |
| Divis Laboratories Ltd | 250,363 | 84.0 | 22.0 % |
| Torrent Pharmaceuticals Ltd | 186,152 | 83.4 | 15.2 % |
| Zydus Lifesciences Ltd | 119,750 | 24.6 | 21.1 % |
| Cipla Ltd | 111,430 | 31.1 | 15.5 % |
| Laurus Labs Ltd | 106,928 | 97.8 | 17.8 % |
| Mankind Pharma Ltd | 105,120 | 49.3 | 13.5 % |
| Dr Reddys Laboratories Ltd | 104,494 | 32.4 | 13.0 % |
| Aurobindo Pharma Ltd | 97,682 | 25.8 | 12.9 % |
| Lupin Ltd | 93,840 | 15.8 | 29.9 % |
| Glenmark Pharmaceuticals Ltd | 68,905 | 22.1 | 39.8 % |
| Alkem Laboratories Ltd | 62,772 | 27.6 | 21.2 % |
| Biocon Ltd | 61,439 | 84.5 | 3.61 % |
| Abbott India Ltd | 57,949 | 35.9 | 44.8 % |
| Gland Pharma Ltd | 49,333 | 43.1 | 15.1 % |
No bulk or block deals on record.
| Ex-date | Action | Factor |
|---|---|---|
| 2015-08-04 | Annual General Meeting (Book Closure Dates Revised) | |
| 2014-07-07 | Annual General Meeting | |
| 2013-07-19 | Annual General Meeting | |
| 2012-07-24 | Annual General Meeting | |
| 2011-12-23 | Scheme Of Arrangement | |
| 2011-07-29 | Annual General Meeting | |
| 2010-07-22 | Annual General Meeting | |
| 2009-07-03 | Annual General Meeting | |
| 2008-07-29 | Annual General Meeting |
No announcements in our files yet.
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Not on any NSE surveillance list in the latest file.
Quick answers
What is the market cap of Piramal Phytocare Ltd(Merged)?
Piramal Phytocare Ltd(Merged) (PIRPHYTO) has a market capitalisation of Rs 58.9 Cr. at the 2019-12-10 close.
What were Piramal Phytocare Ltd(Merged)'s latest quarterly results?
In the Sep 2019 quarter, Piramal Phytocare Ltd(Merged) sales was Rs 7 Cr (+15.2% vs Sep 2018) with a net loss of Rs 2 Cr.